Published in Appl Biochem Biotechnol on October 01, 1998
Formation of different abzymes in autoimmune-prone MRL-lpr/lpr mice is associated with changes in colony formation of haematopoietic progenitors. J Cell Mol Med (2007) 0.85
Affinity and catalytic heterogeneity of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with multiple sclerosis. J Cell Mol Med (2009) 0.83
Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE. Autoimmune Dis (2010) 0.83
Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis. PLoS One (2014) 0.82
Autoantibodies with enzymatic properties in human autoimmune diseases. J Autoimmun (2011) 0.82
A Novel Method for Real-Time, Continuous, Fluorescence-Based Analysis of Anti-DNA Abzyme Activity in Systemic Lupus. Autoimmune Dis (2012) 0.77
Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein. J Cell Mol Med (2015) 0.76
DNA-hydrolysing activity of IgG antibodies from the sera of patients with diseases caused by different bacterial infections. J Cell Mol Med (2008) 0.76
Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis. PLoS One (2016) 0.75
Caspase-dependent cytotoxicity of anti-DNA autoantibodies. Dokl Biochem Biophys (2001) 0.75
DNA hydrolyzing autoantibodies. Science (1992) 1.88
Organization, expression and polymorphism of the human persyn gene. Hum Mol Genet (1998) 1.14
Cleavage of supercoiled plasmid DNA by autoantibody Fab fragment: application of the flow linear dichroism technique. Proc Natl Acad Sci U S A (1995) 1.08
Investigation of the sites phosphorylated in lysine-rich histones by protein kinase from pig brain. FEBS Lett (1975) 0.99
Enzyme mimicry by the antiidiotypic antibody approach. Proc Natl Acad Sci U S A (2000) 0.99
Joint cultivation of human erythroblastoid cells and mouse fibroblasts triggers release of a wide spectrum of cytotoxic factors. Biochem Biophys Res Commun (1997) 0.99
A cyclic adenosine 3',5'-monophosphate-dependent histone kinase from pig brain. Purification and some properties of the enzyme. Biochim Biophys Acta (1975) 0.96
[Molecular mechanisms of cytolytic processes induced by human LAK cells]. Mol Biol (Mosk) (2000) 0.96
Time-dependent changes of LAK cell phenotypes correlate with the secretion of different cytotoxic proteins. Immunol Lett (1993) 0.94
Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol (2008) 0.92
DNA hydrolysis by monoclonal anti-ssDNA autoantibody BV 04-01: origins of catalytic activity. Mol Immunol (1997) 0.90
Different pathways of the release of cytotoxic proteins in LAK cells. Immunol Lett (1996) 0.90
[Expression of cytotoxic factors by cells of nonlymphoid nature are activated upon physical contact with cells of various organisms]. Dokl Akad Nauk (1999) 0.89
Autoantibodies to nuclear antigens: correlation between cytotoxicity and DNA-hydrolyzing activity. Appl Biochem Biotechnol (2000) 0.88
Two realms of dark adaptation. Vision Res (2005) 0.87
Blood Clotting Factor VIII: From Evolution to Therapy. Acta Naturae (2013) 0.86
Molecular pathogenesis of systemic lupus erythematosus. Arch Virol (1975) 0.85
Anti-DNA autoantibodies reveal toxicity to tumor cell lines. Immunol Lett (2002) 0.85
Administration of the cytotoxic complex Tag7-Hsp70 to mice with transplanted tumors inhibits tumor growth. Dokl Biol Sci (2007) 0.84
Immunoproteasome enhances intracellular proteolysis of myelin basic protein. Dokl Biochem Biophys (2014) 0.84
A study of pore formation in lipid bilayers by modular nanotransporters containing the diphtheria toxin translocation domain. Dokl Biochem Biophys (2008) 0.83
Sequence specificity of isolated DNA-adenine methylases from Mycobacterium smegmatis (butyricum) and Shigella sonnei 47 cells. Biochem Int (1985) 0.83
DNA-specific antiidiotypic antibodies in the sera of patients with autoimmune diseases. FEBS Lett (1992) 0.83
[Detection of a perforin-like protein from the soluble cytotoxic factor of natural killer cells]. Mol Biol (Mosk) (1987) 0.82
Comparative analysis of secretion of S100A4 metastatic marker by immune and tumor cells. Bull Exp Biol Med (2008) 0.82
Genomic structure and chromosomal localization of the mouse persyn gene. Genomics (1999) 0.82
Targeted delivery of paclitaxel-loaded recombinant α-fetoprotein fragment-conjugated nanoparticles to tumor cells. Dokl Biochem Biophys (2011) 0.82
Endocarditis with left atrial thrombus formation in Behçet's disease mimicking myxoma. J Rheumatol (1993) 0.82
Contribution of membrane-associated cytotoxic proteins to cytolysis of L929 and K562 target cells mediated by LAK cells with different phenotypes. Immunol Lett (1994) 0.82
[Molecular mechanisms of tumor and immune system interaction]. Vopr Onkol (2008) 0.82
[Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome]. Klin Med (Mosk) (1999) 0.81
Suppression of ongoing experimental allergic encephalomyelitis in DA rats by novel peptide drug, structural part of human myelin basic protein 46-62. Autoimmunity (2009) 0.81
Inhibitory effect of calf fetuin on the cytotoxic activity of LAK cell-derived factors and tumor necrosis factor. Immunol Lett (1994) 0.81
Structure and function of protein kinase from pig brain. Adv Cyclic Nucleotide Res (1978) 0.81
[A study of kinetics of endonuclease reactions using flow linear dichroism technique]. Mol Biol (Mosk) (1997) 0.81
[Site-specificity of DNA methylases from Shigella sonnei 47 cells]. Biokhimiia (1985) 0.80
Sequence specificity of isolated DNA-cytosine methylases from Shigella sonnei 47 cells. Biochem Int (1984) 0.80
Substrate specificity of catalytic autoantibodies in neurodegenerative processes. Dokl Biochem Biophys (2007) 0.80
[An effective inhibitor of gamma-aminobutyric acid transaminase]. Biokhimiia (1969) 0.80
[DNA-hydrolyzing antibodies in lymphoproliferative disorders]. Biull Eksp Biol Med (1996) 0.80
DNA-protein complexes. Natural targets for DNA-hydrolyzing antibodies. Appl Biochem Biotechnol (1994) 0.80
Studies on the mechanism of action of histone kinase dependent on adenosine 3':5'-monophosphate. Evidence for involvement of histidine and lysine residues in the phosphotransferase reaction. Eur J Biochem (1977) 0.79
[Effect of exogenous interferon and various interferon inducers on the indicators of general reactivity in systemic lupus erythematosus]. Ter Arkh (1980) 0.79
DNA hydrolysis by monoclonal autoantibody BV 04-01. Appl Biochem Biotechnol (2000) 0.79
Coagulation Factor IX for Hemophilia B Therapy. Acta Naturae (2012) 0.79
[A novel approach to the study of topoisomerase I kinetics]. Dokl Akad Nauk (1998) 0.78
[The HLA-B5 immunogenetic marker in Behçet's disease]. Ter Arkh (1993) 0.78
Resistance to tumor necrosis factor induced apoptosis in vitro correlates with high metastatic capacity of cells in vivo. Immunol Lett (1999) 0.78
Creation of catalytic antibodies metabolizing organophosphate compounds. Biochemistry (Mosc) (2012) 0.78
Albumin-like glycoprotein from human fetal tissue. Biochem Mol Biol Int (1994) 0.78
[Clinical significance of determining antibodies to poly A: poly U in systemic lupus erythematosus]. Ter Arkh (1972) 0.78
[Catalytic autoantibodies--a new molecular instrument in cardiology and ophthalmology]. Ter Arkh (2006) 0.78
[Atherogenic cholesterol-containing circulating immune complexes--one of the components of the serum in patients with systemic lupus erythematosus]. Klin Med (Mosk) (2003) 0.78
Role of Structure-Based Changes due to Somatic Mutation in Highly Homologous DNA-Binding and DNA-Hydrolyzing Autoantibodies Exemplified by A23P Substitution in the VH Domain. Autoimmune Dis (2012) 0.78
Recombinant human butyrylcholinesterase as a new-age bioscavenger drug: development of the expression system. Acta Naturae (2013) 0.78
[Characteristics of retinal vascular involvement in systemic lupus erythematosus]. Vestn Oftalmol (2001) 0.78
[HLA-E molecule induction on the surface of tumor cells protects them from cytotoxic lymphocytes]. Vopr Onkol (2009) 0.78
[Expression of human serum albumin in metylotrophic yeast Pichia pastoris and its structural and functional analysis]. Bioorg Khim (2008) 0.77
Stable Expression of Recombinant Factor VIII in CHO Cells Using Methotrexate-Driven Transgene Amplification. Acta Naturae (2012) 0.77
Antibodies-antidotes against organophosphorus compounds. Dokl Biochem Biophys (2009) 0.77
DNA-hydrolyzing Ab: is catalytic activity a clue for physiological significance? Autoimmunity (2009) 0.77
[Role of antiphospholipid antibodies in occlusion of retinal vessels in various vascular eye diseases]. Vestn Oftalmol (2002) 0.77
Study of efficiency of the modular nanotransporter for targeted delivery of photosensitizers to melanoma cell nuclei in vivo. Dokl Biochem Biophys (2012) 0.77
[Immunogenetic HLA markers of chronic viral hepatitis]. Ter Arkh (2005) 0.77
[Behçet's disease: clinical and demographic associations]. Ter Arkh (2013) 0.77
Nanoantibodies for detection and blocking of bioactivity of human vascular endothelial growth factor A(165). Biochemistry (Mosc) (2012) 0.77
[Dna-specific catalytic antibodies in human blood sera]. Dokl Akad Nauk SSSR (1991) 0.77
[Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus]. Kardiologiia (2002) 0.77
Disease association and cytotoxic effects of DNA-hydrolyzing autoantibodies. Chem Immunol (2000) 0.76
Substrate specificity of the anthrax lethal factor. Dokl Biochem Biophys (2008) 0.76
[Structural-functional study of recombinant forms of onconase]. Bioorg Khim (2001) 0.76
[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats]. Bioorg Khim (2012) 0.76
[Diagnostic and pathogenetic implications of the site specificity of antibody proteases in multiple sclerosis]. Vestn Ross Akad Med Nauk (2010) 0.76
[DNA-abzymes in rheumatoid arthritis: pathogenetic and clinical significance]. Ter Arkh (2005) 0.76
Site-specific degradation of myelin basic protein by the proteasome. Dokl Biochem Biophys (2009) 0.76
[The current concept of immunological disorders in the case of basal-cell carcinoma]. Arkh Patol (2009) 0.76